Dimpy Koul

5.1k citations

63 papers · 3.7k indexed · h-index 33

Impact in

Genetics top 1%
- Glioma Diagnosis and Treatment
Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research

Papers in

Genetics 16
- Glioma Diagnosis and Treatment 16
Cancer Research 15
- MicroRNA in disease regulation 5

Co-authors: W.K. Alfred Yung Peter A. Steck Gordon B. Mills Michael A. Davies Bharat B. Aggarwal Yiling Lu Shishir Shishodia Ruijun Shen
Journals: Neuro-Oncology (10 papers)Cancer Research (8 papers)Molecular Cancer Therapeutics (4 papers)Clinical Cancer Research (4 papers)Neuro-Oncology Advances (3 papers)
Partner nations: United States Australia Mexico

In The Last Decade

Dimpy Koul

63 papers receiving 3.7k citations

Peers

Countries citing papers authored by Dimpy Koul

Since Specialization

Citations

This map shows the geographic impact of Dimpy Koul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimpy Koul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimpy Koul more than expected).

Fields of papers citing papers by Dimpy Koul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimpy Koul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimpy Koul. The network helps show where Dimpy Koul may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dimpy Koul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dimpy Koul Line = papers co-authored together Dimpy Koul links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Neuronal differentiation drives the antitumor activity of mitogen-activated protein kinase kinase (MEK) inhibition in glioblastoma Neuro-Oncology Advances ·Sabbir Khan, Emmanuel Martínez-Ledesma, Jian‐Wen Dong, Rajasekaran Mahalingam, Soon Young Park, Yuji Piao, Dimpy Koul, Veerakumar Balasubramaniyan, John de Groot, W.K. Alfred Yung	2023	3
2	MGMT function determines the differential response of ATR inhibitors with DNA-damaging agents in glioma stem cells for GBM therapy Neuro-Oncology Advances ·Christoph H. Seibt, Sabbir Khan, Pratibha Sharma, Shaofang Wu, Riya Thomas, Xiaolong Li, Sanjay K. Singh, Frederick F. Lang, Alfred Yung, Dimpy Koul	2023	5
3	EGFR Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma Clinical Cancer Research ·Shaofang Wu, Feng Gao, Siyuan Zheng, Chen Zhang, Emmanuel Martínez-Ledesma, Ravesanker Ezhilarasan, Jie Ding, Xiaolong Li, Ningping Feng, Asha S. Multani, Erik P. Sulman, Roel G.W. Verhaak, John de Groot, Tim Heffernan, W.K. Alfred Yung, Dimpy Koul	2019	34
4	Tie2–FGFR1 Interaction Induces Adaptive PI3K Inhibitor Resistance by Upregulating Aurora A/PLK1/CDK1 Signaling in Glioblastoma Cancer Research ·Xiaolong Li, Emmanuel Martínez-Ledesma, Chen Zhang, Feng Gao, Siyuan Zheng, Jie Ding, Shaofang Wu, Nghi Nguyen, L. Paracchini, Patrick Y. Wen, Keith L. Ligon, W.K. Alfred Yung, Dimpy Koul	2019	20
5	MSK1-Mediated β-Catenin Phosphorylation Confers Resistance to PI3K/mTOR Inhibitors in Glioblastoma Molecular Cancer Therapeutics ·Shaofang Wu, Shuzhen Wang, Siyuan Zheng, Roel G.W. Verhaak, Dimpy Koul, W.K. Alfred Yung	2016	25
6	A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival Genes & Development ·Siyuan Zheng, Jun Fu, Rahulsimham Vegesna, Yong Mao, Lindsey Heathcock, Wandaliz Torres‐García, Ravesanker Ezhilarasan, Shuzhen Wang, Aaron McKenna, Lynda Chin, Cameron Brennan, W.K. Alfred Yung, John N. Weinstein, Kenneth Aldape, Erik P. Sulman, Ken Chen, Dimpy Koul, Roel G.W. Verhaak	2013	51
7	Antitumor Activity of NVP-BKM120—A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells Clinical Cancer Research ·Dimpy Koul, Jun Fu, Ruijun Shen, Tiffany A. LaFortune, Shuzhen Wang, Ningyi Tiao, Yong‐Wan Kim, Juinn-Lin Liu, Chaoran Zhang, Ying Yuan, Hilal Yaqoob, Sauveur-Michel Maira, W.K. Alfred Yung	2011	132
8	Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM Neuro-Oncology ·Young‐Woo Kim, Kelley Evens, Dimpy Koul, Ningyi Tiao, Abdullah Feroze, Jiayi Wang, Garth Powis, W. K. Alfred Yung	2011	29
9	Establishment and characterization of clinically relevant models of ependymoma: a true challenge for targeted therapy Neuro-Oncology ·Su Guan, Rulong Shen, Tiffany A. LaFortune, Ningyi Tiao, Peter J. Houghton, W.K. Alfred Yung, Dimpy Koul	2011	17
10	Exploratory Analysis of the Copy Number Alterations in Glioblastoma Multiforme PLoS ONE ·Pablo R. Freire, Marco Vilela, Helena Deus, Yong‐Wan Kim, Dimpy Koul, Howard Colman, Kenneth Aldape, Oliver Bögler, W. K. Alfred Yung, Kevin R. Coombes, Gordon B. Mills, Ana Tereza Ribeiro de Vasconcelos, Jonas S. Almeida	2008	32
11	Targeting PI3K in Human Glioblastoma with PX-866, a small molecule PI3K inhibitor. Cancer Research ·Dimpy Koul, Ruijun Shen, Kevin P. Culley, S.A. Jakhi, Yasuko Kondo, Garth Powis, Чжун Баонин, WK Alfred Yung	2007	1
12	Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma Cancer Research ·Janice Nigro, Anjan Misra, Li Zhang, Ivan Smirnov, Howard Colman, Chandi Griffin, Natalie Ozburn, Mingang Chen, Edward Pan, Dimpy Koul, W.K. Alfred Yung, Burt G. Feuerstein, Kenneth Aldape	2005	261
13	Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro Breast Cancer Research ·Emmanual Unni, Dimpy Koul, Karin Psohlavcová, Raghu Sinha	2005	52
14	Cyclooxygenase (COX)-2 Inhibitor Celecoxib Abrogates TNF-Induced NF-κB Activation through Inhibition of Activation of IκBα Kinase and Akt in Human Non-Small Cell Lung Carcinoma: Correlation with Suppression of COX-2 Synthesis The Journal of Immunology ·Shishir Shishodia, Dimpy Koul, Bharat B. Aggarwal	2004	165
15	Src Family Protein-tyrosine Kinases Alter the Function of PTEN to Regulate Phosphatidylinositol 3-Kinase/AKT Cascades Journal of Biological Chemistry ·Yiling Lu, Qinghua Yu, Peter Randolph, Jinyi Zhang, Hongwei Wang, Dimpy Koul, John S. McMurray, Xianjun Fang, W.K. Alfred Yung, Kathy Siminovitch, Gordon B. Mills	2003	219
16	MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells Oncogene ·Motoyoshi Tanaka, Dimpy Koul, Michael A. Davies, Monica Liebert, Peter A. Steck, H. Barton Grossman	2000	87
17	Functional and molecular analyses of 10q deletions in human gliomas Genes Chromosomes and Cancer ·Peter A. Steck, Huai Lin, Lauren A. Langford, Samar A. Jasser, Dimpy Koul, W.K. Alfred Yung, Mark A. Pershouse	1999	46
18	p202 self‐associates through a sequence conserved among the members of the 200‐family proteins FEBS Letters ·Dimpy Koul, Nihal Obeyesekere, Jordan U. Gutterman, Gordon B. Mills, Vinay Choubey	1998	20
19	p202 Prevents Apoptosis in Murine AKR-2B Fibroblasts Biochemical and Biophysical Research Communications ·Dimpy Koul, Ruth LaPushin, Hong-Ji Xu, Gordon B. Mills, Jordan U. Gutterman, Divaker Choubey	1998	29
20	Effect of Immunization With Human SP‐10 in Male Rodents American Journal of Reproductive Immunology ·Shobha Sehgal, Dimpy Koul, Seema Verma	1996	10

About Dimpy Koul

Dimpy Koul is a scholar working on Genetics, Cancer Research, Oncology, Molecular Biology and Pathology and Forensic Medicine, having authored 63 papers that have together received 3.7k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (22 papers), Glioma Diagnosis and Treatment (16 papers), Cancer Mechanisms and Therapy (9 papers), DNA Repair Mechanisms (8 papers), CRISPR and Genetic Engineering (7 papers), Cancer-related Molecular Pathways (7 papers), PARP inhibition in cancer therapy (6 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Genetics (820 citations), Cancer Research (892 citations), Molecular Biology (2.6k citations), Oncology (877 citations) and Pathology and Forensic Medicine (369 citations). Dimpy Koul has collaborated with scholars based in United States, Australia and Mexico. Frequent co-authors include W.K. Alfred Yung, Peter A. Steck, Gordon B. Mills, Michael A. Davies, Bharat B. Aggarwal, Yiling Lu, Shishir Shishodia, Ruijun Shen, W.K. Alfred Yung and Tiffany A. LaFortune. Their work appears in journals such as Neuro-Oncology, Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research and Neuro-Oncology Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact